PSMA-PET CT is being increasingly used in clinical practice and is slowly becoming indispensable in the care of many PCa patients by overcoming the challenges of low sensitivity and specificity of conventional imaging modalities. The gene discussed is FOLH1; the disease is posterior cortical atrophy.